About Us

Mission Statement

At DiaCarta, our mission is to improve the lives of cancer patients through innovative precision diagnostics. We are committed to providing accurate, reliable, and affordable diagnostics that help physicians make informed treatment decisions. We foster a collaborative and diverse culture that values teamwork, integrity, and excellence in everything we do. We continuously invest in research and development to push the boundaries of cancer management and bring new hope to patients and their families.


DiaCarta Value

Patient-Centric operations: Our mission is to provide innovative and affordable solutions for cancer patient management, and we prioritize the needs of patients and their families in everything we do.

Innovation: We are committed to advancing precision diagnostics and improving patient outcomes through cutting-edge research and development.

Accuracy and Reliability: We maintain uncompromising standards of accuracy, reliability, and reproducibility in all of our products and services to ensure the best possible outcomes for patients and healthcare providers.

Collaboration: We foster a diverse and inclusive team culture that encourages open communication, collaboration, and mutual respect, both within our organization and with our partners and customers.

Continuous Improvement: We are dedicated to ongoing improvement and innovation, and we invest in the development of our team, our products, and our infrastructure to better serve our customers and achieve our mission.



We are committed to designing and manufacturing products with the good of the patient in mind. We will continuously improve our quality management systems, comply with all applicable regulatory requirements, and build customer confidence by delivering excellent products and services.


Medical & Scientific Advisors



CIO Applications

Top 25 Life Sciences Technology Vendors 2018

The positioning is based on an evaluation of DiaCarta’s specialty in personalized diagnostics, translational genomics and clinical sample testing services provided in both US and China.

med-tech outlook 

Top 10 In-Vitro Diagnostic Technology Solution Providers 2018 

The positioning is based on an evaluation of DiaCarta’s specialty in genomic testing for biomarkers, personalized diagnostics and clinical sample testing service provided in their CLIA-certified lab.

CIO Bulletin

One of the 30 Fastest Growing Companies of 2018

The positioning is based on DiaCarta’s revenue growth, financial status, openness to innovation, global collaboration and partnership, flagship products launching, regulatory progress and ability to forecast future business and technology trends..

The Silicon Review

50 Innovative Companies to Watch in the Year 2018

Winning a spot on this list indicates DiaCarta has distinguished itself from peers by proving itself more valuable in terms of service quality, vast customer base, innovation, and market position

Corporate Governance